Research Article
Epidemiology and Outcome of Ventilator-Associated Pneumonia in a Heterogeneous ICU Population in Qatar
Table 2
Antibiotic sensitivity pattern of bacteria isolated from respiratory specimen of patients with VAP.
| | Antibiotics | Pseudomonas
(%) | Enterobacter
(%) | Klebsiella
(%) | E. coli
(%) | Acinetobacter
(%) | Stenotrophomonas
(%) | Haemophilus
(%) | Staphylococcus
(%) | Streptococcus
(%) |
| | Penicillin-G | — | — | — | — | — | — | — | 7 (33.3%) | 3 (60%) | | Oxacillin | — | — | — | — | — | — | — | 13 (61.9%) | — | | Ampicillin | — | 0 (0%) | 0 (0%) | 1 (20%) | — | — | 15 (93.8%) | — | — | | Amoxicillin/clavulanate | — | 0 (0%) | 16 (64%) | 1 (20%) | — | — | 16 (100%) | — | 5 (100%) | | Piperacillin/tazobactam | 36 (92.3%) | 17 (70.8%) | 20 (80%) | 4 (80%) | 5 (21.7%) | — | — | — | — | | Cefuroxime | — | 2 (8.3%) | 18 (72%) | 1 (20%) | — | — | 15 (93.8%) | — | — | | Ceftriaxone | — | 18 (75%) | 18 (72%) | 1 (20%) | — | — | — | — | 5 (100%) | | Ceftazidime | 33 (84.6%) | — | — | 1 (20%) | 2 (8.7%) | — | — | — | — | | Cefepime | 34 (87.2%) | — | 18 (72%) | 1 (20%) | 4 (17.4%) | — | — | — | — | | Clindamycin | — | — | — | — | — | — | — | 19 (90.5%) | 5 (100%) | | Erythromycin | — | — | — | — | — | — | — | 17 (80.9%) | 5 (100%) | | Vancomycin | — | — | — | — | — | — | — | 21 (100%) | — | | Cotrimoxazole | — | 24 (100%) | 17 (68%) | 1 (20%) | 5 (21.7%) | 4 (100%) | 11 (68.8%) | — | — | | Ciprofloxacin | 36 (92.3%) | 24 (100%) | 24 (96%) | 1 (20%) | 5 (21.7%) | — | — | — | — | | Levofloxacin | — | — | — | — | — | 3 (75%) | — | — | — | | Gentamicin | 36 (92.3%) | 24 (100%) | 25 (100%) | 2 (40%) | 5 (21.7%) | — | — | — | — | | Meropenem | 36 (92.3%) | 23 (95.8%) | 25 (100%) | 5 (100%) | 5 (21.7%) | — | — | — | — | | Colistin | 39 (100%) | — | — | — | 23 (100%) | — | — | — | — |
| | Total number of isolates | 39 | 24 | 25 | 5 | 23 | 4 | 16 | 21 | 5 |
|
|
